Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Global Cohort	STARTED	Standard of Care (SoC)	241
Global Cohort	STARTED	SoC + Durvalumab	238
Global Cohort	STARTED	SoC + Durvalumab + Olaparib	239
Global Cohort	COMPLETED	Standard of Care (SoC)	147
Global Cohort	COMPLETED	SoC + Durvalumab	159
Global Cohort	COMPLETED	SoC + Durvalumab + Olaparib	170
Global Cohort	NOT COMPLETED	Standard of Care (SoC)	94
Global Cohort	NOT COMPLETED	SoC + Durvalumab	79
Global Cohort	NOT COMPLETED	SoC + Durvalumab + Olaparib	69
China Cohort	STARTED	Standard of Care (SoC)	44
China Cohort	STARTED	SoC + Durvalumab	43
China Cohort	STARTED	SoC + Durvalumab + Olaparib	42
China Cohort	COMPLETED	Standard of Care (SoC)	30
China Cohort	COMPLETED	SoC + Durvalumab	29
China Cohort	COMPLETED	SoC + Durvalumab + Olaparib	24
China Cohort	NOT COMPLETED	Standard of Care (SoC)	14
China Cohort	NOT COMPLETED	SoC + Durvalumab	14
China Cohort	NOT COMPLETED	SoC + Durvalumab + Olaparib	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04269200/flow